Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Recall on Single lot of Klonopin Wafers (clonazepam orally disintegrating wafers)
Hoffman La Roche has announced a recall of a single lot of Klonopin 2 mg Wafers (clonazepam orally disintegrating wafers). NDC 0004-0283-22, lot number U5011, expiration date March 2010, is being recalled because it may contain a lower dose of medication than labeled. Klonopin (also sold as the generic clonazepam) is primarily used for the treatment of seizures and panic disorders. For more information, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm161396.htm
Learn More

Recall on Several Lots of Teva / Novopharm Clonazepam 0.5 mg and 1 mg Tablets
Teva Pharmaceuticals and Novopharm Ltd. are recalling several lots of Clonazepam 0.5 mg and 1 mg tablets. These lots are being recalled because the tablets do not meet manufacturing standards for size and potency of the tablet. The product NDC numbers and the lot numbers involved in this recall include the following: 1) Clonazepam Tablets, 0.5 mg with product code NDC 0093-0832-01 or NDC 0093-0832-05 Lot numbers: 35200435A exp 9/2010, 35200408A exp 9/2010, 35200409A exp 9/2010, 35200436A exp 9/2010, 35200437A exp 9/2010, 35200460A exp 9/2010, 35200462A exp 9/2010, and 35200438A exp 9/2010 2) Clonazepam Tablets ,1 mg with a product code NDC 0093-0833-01, NDC 0093-0833-05, or NDC 0093-0833-10 Lot numbers: 35200199A exp 2/2010, 35200200A exp 2/2010, 35200201A exp 2/2010, 35200218A exp 2/2010, 35200219A exp 2/2010, 35200278A exp 2/2010, 35200202A exp 2/2010, 35200248A exp 2/2010, 35200220A exp 2/2010 and 35200203A exp 2/2010 Clonazepam is primarily used for the treatment of seizures and panic disorders. It is also sold under the brand name Klonopin. No other brands or strengths of clonazepam were involved in this recall. For more information, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm189460.htm
Learn More

Date Published Title Drug Source
2009-05-27 Recall on Single lot of Klonopin Wafers (clonazepam orally disintegrating wafers) Clonazepam FDA
2009-11-12 Recall on Several Lots of Teva / Novopharm Clonazepam 0.5 mg and 1 mg Tablets Clonazepam FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Clonidine FDA
2012-03-27 Mylan Technologies, Inc. Recalls Single Lot of Clonidine Transdermal System, 0.2 mg/day Clonidine FDA
2008-11-10 Recommendations for Antiplatelet Therapy (Aspirin, Clopidogrel, or Ticlopdipine) Clopidogrel MediGuard CRT
2008-11-13 Early Communication about Potential Drug Interaction Between PLAVIX and PROTON PUMP INHIBITORS Clopidogrel MediGuard CRT
2009-01-27 FDA Early Communication About an Ongoing Safety Review Clopidogrel FDA
2009-09-16 Low-Dose Aspirin For Prevention Has Fewer Side Effects Than Higher Doses of Aspirin Clopidogrel MediGuard CRT
2009-11-17 Updated Safety Information About A Drug Interaction Between Clopidogrel (Plavix) and Omeprazole (Prilosec, Prilosec OTC) Clopidogrel FDA
2010-03-12 FDA Adds Boxed Warning to Plavix (Clopidogrel) Clopidogrel FDA
2010-10-28 FDA Issues Reminder to Avoid Concomitant Use of Plavix (Clopidogrel) and Omeprazole (Prilosec, Prilosec OTC, Zegerid, Zegerid OTC) Clopidogrel FDA
2013-05-24 Physicians Total Care Recalls Single Lot of Plavix 75 mg Clopidogrel FDA
2008-12-17 New FDA Warning on Seizure Medications Clorazepate FDA
2012-02-02 Glenmark Generics Inc. Recalls Single Lot of Glenmark Clotrimazole Cream Clotrimazole FDA
2009-01-15 Newer Antipsychotics Linked to Heart Risks Clozapine MediGuard CRT
2009-06-08 Antipsychotics Linked With Sudden Cardiac Death Clozapine MediGuard CRT
2009-05-04 FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers FDA
2014-01-15 New FDA Recommendations Aimed at Cutting Risks from Acetaminophen FDA
2007-08-17 Very rare, serious, side effect in nursing mothers Codeine FDA
2009-10-14 FDA Warns Companies to Stop Making Unapproved Codeine Sulfate Tablets Codeine FDA
Back to Consumer Med Safety